- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-33 in Malignancies: Friends or Foes?
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-12-20
DOI
10.3389/fimmu.2018.03051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alcohol, liver disease, and transplantation
- (2018) Philippe Mathurin et al. Current Opinion in Organ Transplantation
- Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ–Dependent Manner
- (2018) Moritz F. Eissmann et al. Cancer Immunology Research
- Immunological Approaches Towards Cancer and Inflammation: A Cross Talk
- (2018) Xinglong Qu et al. Frontiers in Immunology
- A network map of IL-33 signaling pathway
- (2018) Sneha M. Pinto et al. Journal of Cell Communication and Signaling
- Targeting Macrophages in Cancer: From Bench to Bedside
- (2018) Ashleigh R. Poh et al. Frontiers in Oncology
- Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage
- (2018) Ian C. Scott et al. Scientific Reports
- Tumour-associated changes in intestinal epithelial cells cause local accumulation of KLRG1+ GATA3+ regulatory T cells in mice
- (2017) Holger Meinicke et al. IMMUNOLOGY
- MYB-GATA1 fusion promotes basophilic leukaemia: involvement of interleukin-33 and nerve growth factor receptors
- (2017) Stéphane Ducassou et al. JOURNAL OF PATHOLOGY
- IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer
- (2017) Yujiang Fang et al. MEDICAL ONCOLOGY
- Nonimmune cells equipped with T-cell-receptor-like signaling for cancer cell ablation
- (2017) Ryosuke Kojima et al. Nature Chemical Biology
- IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model
- (2017) Kailing Wang et al. Oncotarget
- The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
- (2017) Marie-Hélène Wasmer et al. Frontiers in Immunology
- Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice
- (2017) Zhengxiang He et al. Scientific Reports
- IL-33 signaling fuels outgrowth and metastasis of human lung cancer
- (2016) Chunhong Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular Pathways: The Necrosome—A Target for Cancer Therapy
- (2016) Lena Seifert et al. CLINICAL CANCER RESEARCH
- Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer
- (2016) Christian Schwartz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy
- (2016) Binfeng Lu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis
- (2016) Yu Zhang et al. MOLECULAR CARCINOGENESIS
- Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses
- (2016) Javier Mora et al. Journal of Molecular Cell Biology
- Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
- (2016) Miho Akimoto et al. Nature Communications
- Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia
- (2016) Lei Qin et al. Oncotarget
- Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
- (2016) Iryna Saranchova et al. Scientific Reports
- An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
- (2015) Charlotte O'Donnell et al. BRITISH JOURNAL OF CANCER
- IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2–ERK1/2 Pathway
- (2015) Xi-Xiang Yu et al. DIGESTIVE DISEASES AND SCIENCES
- The Association of Serum IL-33 and sST2 with Breast Cancer
- (2015) Zhi-Ping Yang et al. DISEASE MARKERS
- Liver-Resident Macrophage Necroptosis Orchestrates Type 1 Microbicidal Inflammation and Type-2-Mediated Tissue Repair during Bacterial Infection
- (2015) Camille Blériot et al. IMMUNITY
- Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
- (2015) Xiaoguang Tong et al. Molecular Oncology
- IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance
- (2015) XIAO-LEI YE et al. ONCOLOGY REPORTS
- RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation
- (2015) Susanne V. Schmidt et al. Oncotarget
- Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue
- (2014) Kazuya Ishikawa et al. AURIS NASUS LARYNX
- Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity
- (2014) Daniel O. Villarreal et al. CANCER RESEARCH
- IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy
- (2014) Corinne Cayrol et al. CURRENT OPINION IN IMMUNOLOGY
- Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation
- (2014) Juliana Bessa et al. JOURNAL OF AUTOIMMUNITY
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- Regulated necrosis: the expanding network of non-apoptotic cell death pathways
- (2014) Tom Vanden Berghe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity
- (2014) J Y Kim et al. ONCOGENE
- Significance of Interleukin-33 and Its Related Cytokines in Patients with Breast Cancers
- (2014) Jing Liu et al. Frontiers in Immunology
- Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
- (2013) Kun Gao et al. CANCER LETTERS
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
- (2013) Su-Feng Chen et al. JOURNAL OF PATHOLOGY
- Higher numbers of T-bet+ intratumoral lymphoid cells correlate with better survival in gastric cancer
- (2012) Lu-jun Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer-Related Inflammation
- (2012) Juliana Candido et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
- (2011) Ivan Jovanovic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- RIP3 mediates the embryonic lethality of caspase-8-deficient mice
- (2011) William J. Kaiser et al. NATURE
- IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
- (2010) J. C. Markley et al. BLOOD
- Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis
- (2010) G. Trichonas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started